We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.28%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.53B
AUM Growth
-$382M
Cap. Flow
+$195M
Cap. Flow %
2.99%
Top 10 Hldgs %
59.37%
Holding
305
New
83
Increased
54
Reduced
76
Closed
50

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$108M
2
BUD icon
AB InBev
BUD
+$39.8M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$33.9M
4
CRL icon
Charles River Laboratories
CRL
+$32M
5
CL icon
Colgate-Palmolive
CL
+$27M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$93.3M
2
PFE icon
Pfizer
PFE
+$76.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$53.7M
4
INCY icon
Incyte
INCY
+$46.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.38%
2 Consumer Staples 6.6%
3 Technology 4.23%
4 Consumer Discretionary 3.89%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDBLW
251
Edible Garden AG Warrant
EDBLW
$65.4K
$672 ﹤0.01%
26,667
– –
DRMAW icon
252
Dermata Therapeutics Warrant
DRMAW
$12.4K
$355 ﹤0.01%
20,313
– –
GMBLZ
253
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$216 ﹤0.01%
27,000
– –
AREBW
254
DELISTED
American Rebel Holdings Warrants
AREBW
$193 ﹤0.01%
193
– –
ASNS
255
DELISTED
ACTELIS NETWORKS INC
ASNS
– –
-18,533
Closed -$589K
BLTE
256
Belite Bio
BLTE
$6.54B
– –
-210,915
Closed -$3.01M
CHWY icon
257
Chewy
CHWY
$9.63B
– –
-60,000
Closed -$2.37M
CISS
258
C3is
CISS
$129K
– –
0
– -$113K
CNVS icon
259
Cineverse
CNVS
$65.6M
– –
-919,333
Closed -$1.75M
CWH icon
260
Camping World
CWH
$653M
– –
-60,000
Closed -$1.81M
ENR icon
261
Energizer
ENR
$1.55B
– –
-930,000
Closed -$31.2M
ESPR
262
DELISTED
Esperion Therapeutics
ESPR
– –
-9,193,000
Closed -$12.8M
INMD icon
263
InMode
INMD
$880M
– –
-236,000
Closed -$8.81M
KVUE icon
264
Kenvue
KVUE
$36.9B
– –
-300,000
Closed -$7.93M
LVS icon
265
Las Vegas Sands
LVS
$29.6B
– –
-67,500
Closed -$3.92M
MBOT icon
266
Microbot Medical
MBOT
$127M
– –
-385,246
Closed -$1.05M
MDGL icon
267
PUT
Madrigal Pharmaceuticals
MDGL
$11.8B
– –
-320,000
Closed -$73.9M
MHK icon
268
Mohawk Industries
MHK
$9.22B
– –
-36,000
Closed -$3.71M
BGDE
269
Big Digital Energy Inc
BGDE
$32M
– –
-69,000
Closed -$2.61M
MLCO icon
270
Melco Resorts & Entertainment
MLCO
$2.14B
– –
-215,000
Closed -$2.63M
NRXP icon
271
NRX Pharmaceuticals
NRXP
$153M
– –
-563,600
Closed -$2.73M
ORLY icon
272
O'Reilly Automotive
ORLY
$76.3B
– –
-169,500
Closed -$10.8M
PFE icon
273
Pfizer
PFE
$153B
– –
-2,096,000
Closed -$76.9M
PG icon
274
Procter & Gamble
PG
$339B
– –
-210,000
Closed -$31.9M
PODD icon
275
Insulet
PODD
$9.79B
– –
-28,000
Closed -$8.07M
9 10
11
12 13

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Armistice Capital held 305 positions worth $6.53B, down 5.5% from $6.91B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Armistice Capital's Q3 2023 filing shows 83 new, 54 increased, 76 reduced and 50 closed positions. Its largest new stake was AB InBev: 703,000 shares worth $38.9M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $93.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q3 2023 buy was AB InBev: 703,000 shares worth $38.9M.
  • Armistice Capital added most to PTC Therapeutics in Q3 2023, an estimated $108M increase.
  • Armistice Capital's biggest Q3 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $93.3M.
  • Armistice Capital fully exited Pfizer in Q3 2023, selling an estimated $76.9M.
  • Armistice Capital's ten largest holdings make up 59% of its $6.53B portfolio in Q3 2023.
  • Armistice Capital opened 83 new positions and closed 50 in Q3 2023.
  • Armistice Capital's portfolio value fell 5.5% quarter-over-quarter to $6.53B.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.